Chunmei Wang

Papers

1

Total Citations

7

H-Index

1

About

Chunmei Wang is a rising leader in urologic surgery whose work is advancing the evidence base for treating benign prostatic hyperplasia (BPH). Her research focuses on comparing modern surgical techniques, particularly the efficacy and safety of holmium laser enucleation of the prostate (HoLEP) versus robotic-assisted simple prostatectomy (RASP). Wang’s most-cited study, a 2025 systematic review and meta-analysis, synthesizes outcomes from multiple trials to guide surgeons in selecting the optimal minimally invasive approach for large prostates. This work has already garnered 7 citations, signaling its rapid uptake by the urology community. Beyond this landmark paper, Wang contributes to refining perioperative protocols and patient selection criteria, helping to reduce complications and improve recovery times. Her meta-analytical skills and commitment to comparative effectiveness research make her a valuable voice in the ongoing debate over laser versus robotic techniques. As her citation profile grows, Chunmei Wang is establishing herself as a key researcher shaping the future of BPH surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Comparative outcomes of holmium laser enucleation of the prostate (HoLEP) versus robotic-assisted simple prostatectomy (RASP) for benign prostatic hyperplasia: a systematic review and meta-analysis
7 citations · 2025
📈 Most Prolific Year: 2025 (1 Papers)
🤝 Key Collaborators: 6

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago